Evidence map›Paper›PMID 27488617›Full record

ArticleScientific reports2016

The environmental carcinogen benzo[a]pyrene induces a Warburg-like metabolic reprogramming dependent on NHE1 and associated with cell survival.

Kévin Hardonnière, Elise Saunier, Anthony Lemarié, Morgane Fernier, Isabelle Gallais, Cécile Héliès-Toussaint, Baharia Mograbi, Samantha Antonio, Paule Bénit, Pierre Rustin and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Draft genome sequence of benzo[a]pyrene degradingMicrobiology resource announcements · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Protective Effect ofNutrients · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Benzo[International journal of molecular sciences · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Pathophysiology of hepatic NaExperimental and therapeutic medicine · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 1 country.

Kévin HardonnièreInstitut national de la santé et de la recherche médicale (Inserm), Institut de recherche en santé, environnement et travail (Irset - Inserm UMR 1085), F-35043 Rennes, France.
Elise SaunierInserm UMR 1124, Université Paris Descartes, Centre Universitaire des Saints-Pères, Paris, France.
Anthony LemariéInserm-U1037, University of Toulouse, Cancer Research Center of Toulouse CRCT, Department of Experimental Therapeutics 2 av. Hubert Curien, 31100 Toulouse, France.
Morgane FernierInstitut national de la santé et de la recherche médicale (Inserm), Institut de recherche en santé, environnement et travail (Irset - Inserm UMR 1085), F-35043 Rennes, France.
Isabelle GallaisInstitut national de la santé et de la recherche médicale (Inserm), Institut de recherche en santé, environnement et travail (Irset - Inserm UMR 1085), F-35043 Rennes, France.
Cécile Héliès-ToussaintINRA UMR 1331 ToxAlim (Research Center in Food Toxicology), University of Toulouse ENVT, INP, UPS, 180 Chemin de Tournefeuille, F-31027, France.
Baharia MograbiInstitute of Research on Cancer and Ageing of Nice (IRCAN), INSERM U1081, CNRS UMR7284, Université de Nice-Sophia Antipolis, Faculté de Médecine, Centre Antoine Lacassagne, Nice, F-06107, France.
Samantha AntonioInserm UMR 1124, Université Paris Descartes, Centre Universitaire des Saints-Pères, Paris, France.
Paule BénitHôpital Robert Debré, INSERM UMR1141, Bâtiment Ecran, 48 Boulevard Sérurier, Paris 75019, France.
Pierre RustinHôpital Robert Debré, INSERM UMR1141, Bâtiment Ecran, 48 Boulevard Sérurier, Paris 75019, France.
Maxime JaninInserm UMR 1124, Université Paris Descartes, Centre Universitaire des Saints-Pères, Paris, France.
Florence HabarouInserm UMR 1124, Université Paris Descartes, Centre Universitaire des Saints-Pères, Paris, France.
Chris OttolenghiInserm UMR 1124, Université Paris Descartes, Centre Universitaire des Saints-Pères, Paris, France.
Marie-Thérèse LavaultUniversité de Rennes 1, Structure fédérative de recherche Biosit, UMS CNRS 3480/US Inserm 018, F 35043 Rennes, France.
Chantal BenelliInserm UMR 1124, Université Paris Descartes, Centre Universitaire des Saints-Pères, Paris, France.
Odile SergentInstitut national de la santé et de la recherche médicale (Inserm), Institut de recherche en santé, environnement et travail (Irset - Inserm UMR 1085), F-35043 Rennes, France.
Laurence HucINRA UMR 1331 ToxAlim (Research Center in Food Toxicology), University of Toulouse ENVT, INP, UPS, 180 Chemin de Tournefeuille, F-31027, France.
Sylvie BortoliInserm UMR 1124, Université Paris Descartes, Centre Universitaire des Saints-Pères, Paris, France.
Dominique Lagadic-GossmannInstitut national de la santé et de la recherche médicale (Inserm), Institut de recherche en santé, environnement et travail (Irset - Inserm UMR 1085), F-35043 Rennes, France.
Inserm · FRUniversité Paris Cité · FRDélégation Paris 5 · FRStructure Fédérative de Recherche en Biologie et Santé de Rennes · FRCentre National de la Recherche Scientifique · FRÉcole Nationale Vétérinaire de Toulouse · FRInstitut de Recherche en Santé, Environnement et Travail · FRInstitut de Recherche sur le Cancer et le Vieillissement de Nice · FRUniversité de Rennes · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cells display alterations in many cellular processes. One core hallmark of cancer is the Warburg effect which is a glycolytic reprogramming that allows cells to survive and proliferate. Although the contributions of environmental contaminants to cancer development are widely accepted, the underlying mechanisms have to be clarified. Benzo[a]pyrene (B[a]P), the prototype of polycyclic aromatic hydrocarbons, exhibits genotoxic and carcinogenic effects, and it is a human carcinogen according to the International Agency for Research on Cancer. In addition to triggering apoptotic signals, B[a]P may induce survival signals, both of which are likely to be involved in cancer promotion. We previously suggested that B[a]P-induced mitochondrial dysfunctions, especially membrane hyperpolarization, might trigger cell survival signaling in rat hepatic epithelial F258 cells. Here, we further characterized these dysfunctions by focusing on energy metabolism. We found that B[a]P promoted a metabolic reprogramming. Cell respiration decreased and lactate production increased. These changes were associated with alterations in the tricarboxylic acid cycle which likely involve a dysfunction of the mitochondrial complex II. The glycolytic shift relied on activation of the Na(+)/H(+) exchanger 1 (NHE1) and appeared to be a key feature in B[a]P-induced cell survival related to changes in cell phenotype (epithelial-to-mesenchymal transition and cell migration).

Indexed as

AnimalsBenzo(a)pyreneCarcinogens, EnvironmentalCell LineCell SurvivalCellular ReprogrammingCitric Acid CycleEnergy MetabolismEpithelial CellsEpithelial-Mesenchymal TransitionLactic AcidLiverRatsSodium-Hydrogen Exchanger 1Benzo(a)pyreneCarcinogens, EnvironmentalLactic AcidSlc9a1 protein, ratSodium-Hydrogen Exchanger 1

Identifiers

PMID27488617
PMCPMC4973274
OpenAlexW2485821550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.